Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Mycronic AB (publ)    MYCR   SE0000375115

MYCRONIC AB (PUBL)

(MYCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Mycronic publ : Board of Directors proposes changed dividend

03/26/2020 | 07:01am EST

Due to the great uncertainty created by the spread of the coronavirus, the Board of Directors of Mycronic AB (publ) has decided to propose the Annual General Meeting on May 7 2020 that the dividend is changed from the earlier communicated 3.25 SEK per share, to a dividend of 2.00 SEK per share.

"After the record year 2019 Mycronic has a strong financial position and liquidity. The company wants to be well prepared to take advantage of future opportunities that might arise and the Board of Directors therefore wishes to be prudent. Considering the prevailing uncertainty, the proposal is well-balanced", says Anders Lindqvist, President and CEO at Mycronic.

For additional information, please contact:
Anders Lindqvist
President and CEO
Tel: +46 8 638 52 00
anders.lindqvist@mycronic.com

Tobias Bülow
Director Investor Relations
Tel: +46 734 018 216
tobias.bulow@mycronic.com

The information is of the type that Mycronic is required to disclose in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the contact persons stated above, on March 26, 2020, at 1:00 p.m.

About Mycronic
Mycronic AB is a high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, the Netherlands, Singapore, South Korea, United Kingdom and the United States. Mycronic is listed on NASDAQ Stockholm. www.mycronic.com

https://news.cision.com/mycronic-ab/r/mycronic-s-board-of-directors-proposes-changed-dividend,c3069540

https://mb.cision.com/Main/10432/3069540/1218419.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about MYCRONIC AB (PUBL)
2020MYCRONIC : receives order for SLX system
AQ
2020MYCRONIC : receives order for two SLX mask writers
AQ
2020MYCRONIC : announces strategic partnership with Cogiscan to provide machine conn..
AQ
2020MYCRONIC : receives order for a SLX and a Prexision Lite 8 Evo mask writer
AQ
2020MYCRONIC : Interim Report January-September 2020
AQ
2020MYCRONIC : appoints Nomination Committee
AQ
2020MYCRONIC AB (PUBL) : Ex-dividend day for final dividend
FA
2020MYCRONIC PUBL : Communiqué from the AGM and statutory Board meeting of Mycronic ..
AQ
2020MYCRONIC PUBL : Welcome to the Annual General meeting in Mycronic AB (publ)
AQ
2020MYCRONIC AB (PUBL) : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2020 3 937 M 469 M 469 M
Net income 2020 692 M 82,5 M 82,5 M
Net cash 2020 937 M 112 M 112 M
P/E ratio 2020 35,4x
Yield 2020 1,13%
Capitalization 24 444 M 2 919 M 2 914 M
EV / Sales 2020 5,97x
EV / Sales 2021 5,23x
Nbr of Employees 1 505
Free-Float 72,2%
Chart MYCRONIC AB (PUBL)
Duration : Period :
Mycronic AB (publ) Technical Analysis Chart | MYCR | SE0000375115 | MarketScreener
Technical analysis trends MYCRONIC AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 201,00 SEK
Last Close Price 250,00 SEK
Spread / Highest target -10,0%
Spread / Average Target -19,6%
Spread / Lowest Target -32,8%
EPS Revisions
Managers and Directors
NameTitle
Per Anders Lindqvist President & Chief Executive Officer
Patrik Tigerschiöld Chairman
Lena Båvegård Senior Vice President-Operations
August Torbjörn Gunnar Wingardh Chief Financial Officer
Johan Franzén Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
MYCRONIC AB (PUBL)1.87%2 919
ASML HOLDING N.V.9.63%216 409
LAM RESEARCH CORPORATION15.94%78 849
TOKYO ELECTRON LIMITED14.32%65 754
QORVO, INC.10.63%20 221
ASE TECHNOLOGY HOLDING CO., LTD.20.54%14 935